EverSource Wealth Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.1K Sell
611
-215
-26% -$26K ﹤0.01% 1609
2026
Q1
$135K Buy
826
+79
+11% +$12.1K ﹤0.01% 1259
2025
Q4
$130K Buy
747
+69
+10% +$12.6K ﹤0.01% 1177
2025
Q3
$97.6K Buy
678
+14
+2% +$1.72K ﹤0.01% 1296
2025
Q2
$66.8K Buy
664
+263
+66% +$20.1K ﹤0.01% 1435
2025
Q1
$30.6K Buy
401
+84
+26% +$6.43K ﹤0.01% 1468
2024
Q4
$21.9K Buy
317
+55
+21% +$3.96K ﹤0.01% 1577
2024
Q3
$19.1K Buy
262
+88
+51% +$6.49K ﹤0.01% 1519
2024
Q2
$12.7K Buy
174
+78
+81% +$3.02K ﹤0.01% 1734
2024
Q1
$2.37K Hold
96
– – ﹤0.01% 2324
2023
Q4
$2.98K Hold
96
– – ﹤0.01% 2057
2023
Q3
$2.42K Hold
96
– – ﹤0.01% 1956
2023
Q2
$2.03K Buy
96
+71
+284% +$1.35K ﹤0.01% 2023
2023
Q1
$426 Buy
+25
New +$486 ﹤0.01% 2260
2022
Q2
– Sell
-181
Closed -$4K – 1794
2022
Q1
$4K Hold
181
– – ﹤0.01% 1335
2021
Q4
$5K Buy
+181
New +$5.17K ﹤0.01% 1260

Other funds holding INSM

EverSource Wealth Advisors's INSM Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Insmed (INSM) stake by 26% in Q2 2026, selling an estimated $26K and leaving 611 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

EverSource Wealth Advisors first reported a position in INSM in Q4 2021 and has held it in 16 quarters since. The position peaked at $135K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • EverSource Wealth Advisors held 611 shares of Insmed worth $65.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 215 Insmed shares in Q2 2026, an estimated $26K.
  • Insmed made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1609 holding.
  • EverSource Wealth Advisors first reported a position in Insmed in Q4 2021 and has held it in 16 quarters since.
  • EverSource Wealth Advisors's Insmed position peaked at $135K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.